Table 4

Details of all cases of CIN2+ detected during follow-up of 1020 patients who had received treatment for cervical disease

Case number	HC2 RLU/CO	COBAS (with typing)	rtHPV (with typing)	Cervista (HPV species)	Aptima (with value)	Cytology	Histology
1	777.61	16	16	A9	10.79	Severe dyskaryosis	CIN 3
2	242.09	16	16	A9	10.22	Mild dyskaryosis	CIN 3
3	1095.42	Other HR-HPV	Other HR-HPV	A5/6	7.41	Moderate dyskaryosis	CIN 3
4	6.04	Other HR-HPV	Other HR-HPV	A5/6, A9	4.85	Borderline squamous changes	CIN 2
5	2777.21	16,Other HR-HPV	16, Other HR-HPV	A7, A9	19.02	Severe dyskaryosis	CIN 2
6	327.67	Other HR-HPV	Other HR-HPV	A9	16.87	Moderate dyskaryosis	CIN 2
7	273.43	16	16	A9	10.16	Severe dyskaryosis	CIN 3
8	61.89	16	16	A9	10.07	Moderate dyskaryosis	CIN 3
9	247.1	16	16	A9	10.46	Severe dyskaryosis	CIN 3
10	2.37	Other HR-HPV	Other HR-HPV	Negative	Negative	Negative	CIN 2
11	894.48	Other HR-HPV	Other HR-HPV	A9	9.6	Mild dyskaryosis	CIN 3
12	180.4	Other HR-HPV	Other HR-HPV	A9	17.49	Moderate dyskaryosis	CIN 3
13	2209.85	16	16	A5/6, A9	9.62	Mild dyskaryosis	CIN 2
14	2762.86	16	16	A9	12.4	Moderate dyskaryosis	CIN 3
15	2224.68	16,Other HR-HPV	Other HR-HPV	A5/6, A9	20.06	Moderate dyskaryosis	CIN 2
16	132.39	16	16	A9	11.8	Moderate dyskaryosis	CIN 3
17	13.79	16	16	A9	11.73	Severe dyskaryosis	CIN 2
18	964.15	16	16	A5/6, A9	10.53	Severe dyskaryosis	CIN 3
19	445.86	Other HR-HPV	Other HR-HPV	A5/6	7.98	Negative	CIN 2
20	4.39	16,Other HR-HPV	16, Other HR-HPV	A7	18.74	Severe dyskaryosis	CIN 3
21	539.15	16,Other HR-HPV	16, Other HR-HPV	A9	11.24	Severe dyskaryosis	CIN 3
22	1.85	Other HR-HPV	Other HR-HPV	A5/6	Negative	Negative	CIN 2
23	5.87	16	16	A9	10.27	Severe dyskaryosis	Invasive SCC

CIN, cervical intraepithelial neoplasia; HC2, hybrid capture 2 test; HPV, human papillomavirus; HR-HPV, high risk HPV; rtHPV, real time HPV test; RLU/CO, relative light unit/cut off.